These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 34169702)
1. Vaccines for COVID-19 in patients with atopic dermatitis: three things every dermatologist should know. Diotallevi F; Simonetti O; Radi G; Molinelli E; Rizzetto G; Cirioni O; D'Errico MM; Offidani A Acta Dermatovenerol Alp Pannonica Adriat; 2021 Jun; 30(2):67-69. PubMed ID: 34169702 [TBL] [Abstract][Full Text] [Related]
2. Vaccines Against SARS-CoV-2 in Psoriasis Patients on Immunosuppressive Therapy: Implications of Vaccination Nationwide Campaign on Clinical Practice in Italy. Diotallevi F; Campanati A; Radi G; Martina E; Rizzetto G; Barbadoro P; D'Errico MM; Offidani A Dermatol Ther (Heidelb); 2021 Dec; 11(6):1889-1903. PubMed ID: 34586598 [TBL] [Abstract][Full Text] [Related]
3. Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management. Simonetti O; Radi G; Molinelli E; Rizzetto G; Diotallevi F; Offidani A Hum Vaccin Immunother; 2021 Oct; 17(10):3268-3275. PubMed ID: 34170791 [TBL] [Abstract][Full Text] [Related]
4. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336 [TBL] [Abstract][Full Text] [Related]
5. Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines. Schulze-Koops H; Specker C; Skapenko A RMD Open; 2021 Feb; 7(1):. PubMed ID: 33627439 [TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid use in patients with adrenal insufficiency following administration of the COVID-19 vaccine: a pituitary society statement. Katznelson L; Gadelha M Pituitary; 2021 Apr; 24(2):143-145. PubMed ID: 33564969 [TBL] [Abstract][Full Text] [Related]
10. Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19). Bennet BM; Wolf J; Laureano R; Sellers RS Toxicol Pathol; 2020 Oct; 48(7):800-809. PubMed ID: 32926660 [TBL] [Abstract][Full Text] [Related]
11. The Century of mRNA Vaccines: COVID-19 Vaccines and Allergy. Ortega Rodríguez NR; Audícana Berasategui MT; de la Hoz Caballer B; Valero Santiago A J Investig Allergol Clin Immunol; 2021 Feb; 31(1):89-91. PubMed ID: 33393485 [No Abstract] [Full Text] [Related]
12. Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development. Ita K Arch Med Res; 2021 Jan; 52(1):15-24. PubMed ID: 32950264 [TBL] [Abstract][Full Text] [Related]
14. Understanding the dynamics of COVID-19; implications for therapeutic intervention, vaccine development and movement control. Salvamani S; Tan HZ; Thang WJ; Ter HC; Wan MS; Gunasekaran B; Rhodes A Br J Biomed Sci; 2020 Oct; 77(4):168-184. PubMed ID: 32942955 [TBL] [Abstract][Full Text] [Related]
15. Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts. Ring J; Worm M; Wollenberg A; Thyssen JP; Jakob T; Klimek L; Bangert C; Barbarot S; Bieber T; de Bruin-Weller MS; Chernyshov PV; Christen-Zaech S; Cork M; Darsow U; Flohr C; Fölster-Holst R; Gelmetti C; Gieler U; Gutermuth J; Heratizadeh A; Hijnen DJ; von Kobyletzki LB; Kunz B; Paul C; De Raeve L; Seneschal J; Simon D; Spuls PI; Stalder JF; Svensson A; Szalai Z; Taieb A; Torrelo A; Trzeciak M; Vestergaard C; Werfel T; Weidinger S; Deleuran M J Eur Acad Dermatol Venereol; 2021 Jun; 35(6):e362-e365. PubMed ID: 33752263 [No Abstract] [Full Text] [Related]
16. Deciphering Vaccines for COVID-19: where do we stand today? Baviskar T; Raut D; Bhatt LK Immunopharmacol Immunotoxicol; 2021 Feb; 43(1):8-21. PubMed ID: 33054486 [TBL] [Abstract][Full Text] [Related]
17. Coronavirus Vaccination Adverse Reactions and the Role of the Dermatologist. Pulsipher KJ; Presley CL; Waller JD; Szeto MD; Laughter MR; Dellavalle RP J Drugs Dermatol; 2021 Mar; 20(3):351-352. PubMed ID: 33683080 [No Abstract] [Full Text] [Related]
18. COVID-19 vaccine trials: The use of active controls and non-inferiority studies. Fleming TR; Krause PR; Nason M; Longini IM; Henao-Restrepo AM Clin Trials; 2021 Jun; 18(3):335-342. PubMed ID: 33535811 [TBL] [Abstract][Full Text] [Related]
19. Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases. Furer V; Rondaan C; Agmon-Levin N; van Assen S; Bijl M; Kapetanovic MC; de Thurah A; Mueller-Ladner U; Paran D; Schreiber K; Warnatz K; Wulffraat NM; Elkayam O RMD Open; 2021 Feb; 7(1):. PubMed ID: 33627440 [TBL] [Abstract][Full Text] [Related]
20. Is there a role for childhood vaccination against COVID-19? Eberhardt CS; Siegrist CA Pediatr Allergy Immunol; 2021 Jan; 32(1):9-16. PubMed ID: 33113210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]